Research Directions: Closing the Global Evidence Gap
The single highest-value, lowest-cost research action to test the hidden-burden thesis: add a minimal PEM-screening module to existing post-dengue, post-chikungunya, and post-Zika cohort follow-up studies in Brazil, India, Vietnam, and Thailand. A 5-item PEM screen (DSQ-PEM subscale, translated + back-translated) plus a 1-minute sit-to-stand test (heart rate pre/post, manual pulse or smartphone) costs less than USD 5 per participant and requires no laboratory infrastructure. Deployment at 5 sentinel sites would generate the first systematic post-arboviral ME/CFS prevalence estimates with confidence intervals. Total cost: USD 150K–300K — less than one NIH R01.
(Origin: brainstorm. Certainty: 0.40 — epidemiological feasibility. Cohorts exist; module is minimal and low-cost; PEM screening in translated instruments is methodologically challenging — cultural equivalence of “exertion” and “worsening” not established for all settings.)
Consequence: For USD 300K, we could answer whether millions of dengue survivors in Asia and Latin America have unrecognized ME/CFS. The fact this study has not been done is the research-equivalent of the diagnostic gap this chapter describes. Severity applicability: all — screening across severity levels depends on follow-up visit accessibility.
Falsifiable prediction: If 5-site sentinel PEM screening in post-dengue cohorts (n≥500 per site) finds PEM prevalence below 1% across all sites (upper bound of 95% CI under 3%), the hidden-burden thesis is refuted for dengue-triggered ME/CFS. If prevalence is ≥5% at ≥3 sites, the thesis is strongly supported and the chapter’s central claim shifts from hypothesis to finding.
The IOM 2015 SEID criteria operationalize PEM as “worsening of symptoms after physical, cognitive, or emotional exertion that was previously tolerated.” In agrarian/subsistence-livelihood settings, “exertion” has no discrete boundary — work is continuous, rest is minimal, and “previously tolerated” has no reference point. In South Asian idioms, “weakness” (kamzori) may substitute for “fatigue” as the primary complaint. In Swahili-speaking East Africa, “thinking too much” (kufikiri sana) may capture cognitive PEM better than “brain fog.” A culturally adapted PEM screening instrument — developed through cognitive interviews, back-translated, and validated against IOM clinical diagnosis — would enable the first valid prevalence estimates in non-Western settings. The tool must be adapted, not just translated.
(Origin: brainstorm. Certainty: 0.35 — cognitive interview methodology is standard; the gold-standard circularity problem is inherent: we need culturally adapted criteria to identify patients to validate the culturally adapted tool.)
Consequence: Before we can count ME/CFS patients in India or Bangladesh, we need a way to ask about PEM that makes sense in Hindi, Bengali, and Swahili — not just a translation of “do you feel worse after exertion?” to someone who has never had the luxury of distinguishing exertion from survival. Severity applicability: all.